| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.092 | 0.04 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.043 | 0.3 |